Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleMaximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsJohn R Floyd, Andrew Brenner